White Paper on the Value of Time Savings for Patients and Healthcare Providers of Breast Cancer Therapy: The Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection as an Example

MLA

Jackisch, Christian, et al. “White Paper on the Value of Time Savings for Patients and Healthcare Providers of Breast Cancer Therapy: The Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection as an Example.” Advances in Therapy, vol. 39, Jan. 2022, pp. 833–44. EBSCOhost, https://doi.org/10.1007/s12325-021-01996-0.

APA

Jackisch, C., Manevy, F., Frank, S., Roberts, N., & Shafrin, J. (2022). White Paper on the Value of Time Savings for Patients and Healthcare Providers of Breast Cancer Therapy: The Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection as an Example. Advances in Therapy, 39, 833–844. https://doi.org/10.1007/s12325-021-01996-0

Chicago

Jackisch, Christian, Federico Manevy, Suzanne Frank, Nicki Roberts, and Jason Shafrin. 2022. “White Paper on the Value of Time Savings for Patients and Healthcare Providers of Breast Cancer Therapy: The Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection as an Example.” Advances in Therapy 39 (January): 833–44. doi:10.1007/s12325-021-01996-0.